He completed his PhD degree in pharmacology at University of Missouri-Columbia and his post-doctoral training at the Department of Neurology, Washington University. Dr. Han is focused on the cellular and molecular mechanisms underlying neurovascular degeneration and dysfunction associated with neurovascular disorders including Alzheimer’s disease, cerebral amyloid angiopathy, aneurysmal subarachnoid hemorrhage and ischemic stroke. He is interested in preclinical research to identify therapeutic targets and novel therapeutics for central nervous system disorders. His lab is also working on development of positron emission tomography (PET) imaging tracers for the diagnosis of cerebral amyloid angiopathy. Biography